Skip to main content
TipRanks
Go Ultimate75% OFF

Castle Biosciences (CSTL) Q2 2026 Earnings Report

474 Followers

CSTL Q2 2026 EPS Results

Actual EPS
-$0.07
Consensus EPS
-$0.41
Beat/Miss
Beat by +$0.34
One Year Ago EPS
$0.15

CSTL Q2 2026 Revenue Results

Actual Revenue
$103.55M
Expected Revenue
$86.23M
Beat/Miss
Beat by +$17.31M
YoY Revenue Growth
+20.14%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
After Close
Conference Call
Thursday, July 30, 2026
CSTL Upcoming Earnings

Castle Biosciences's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CSTL Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

CSTL Earnings History

CSTL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.15--0.08――
Nov 05, 20262026 (Q3)-0.35-0.13-0.02-550.00% (-0.11)
Jul 30, 20262026 (Q2)-0.41-0.070.15-146.67% (-0.22)
May 06, 20262026 (Q1)-0.49-0.49-0.945.56% (+0.41)
Feb 26, 20262025 (Q4)-0.26-0.080.32-125.00% (-0.40)
Nov 03, 20252025 (Q3)-0.52-0.020.08-125.00% (-0.10)
Aug 04, 20252025 (Q2)-0.530.150.31-51.61% (-0.16)
May 05, 20252025 (Q1)-0.07-0.90-0.09-900.00% (-0.81)
Feb 27, 20252024 (Q4)0.050.32-0.1420.00% (+0.42)
Nov 04, 20242024 (Q3)-0.000.08-0.26130.77% (+0.34)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed